Literature DB >> 18475696

Serum levels of total IgE and soluble CD23 in bronchial asthma.

G D Lorenzo1, P Mansueto, M Melluso, G Morici, D Cigna, G Candore, C Caruso.   

Abstract

The aim of the present study was to compare, during the pollen season, serum levels of total IgE and soluble CD23 (sCD23) from patients with allergic bronchial asthma, with those from healthy subjects. Significantly higher levels of total IgE and sCD23 were found in patients with asthma compared to the control group. Both in normal controls and in asthmatic patients, a significant correlation was shown between the levels of these two molecules. In asthmatic patients, significant correlations were found for both total IgE and sCD23, with lung function measured as bronchial responsiveness to inhaled methacholine. These results suggest that in asthmatic patients, in addition to the study of total serum IgE levels, the assessment of sCD23 serum levels may be helpful in the evaluation of disease activity.

Entities:  

Year:  1996        PMID: 18475696      PMCID: PMC2365763          DOI: 10.1155/S0962935196000075

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  14 in total

1.  The relationship between atopy and non-specific bronchial responsiveness.

Authors:  D N Grainger; S C Stenton; A J Avery; M Duddridge; E H Walters; D J Hendrick
Journal:  Clin Exp Allergy       Date:  1990-03       Impact factor: 5.018

2.  Prediction of the development of atopic symptoms in early childhood by cord IgE-binding factors (soluble Fc epsilon R2).

Authors:  K M Kim; Y Inoue; Y Uenoyama; K Mutoh; J Yodoi; M Kaneshima; M Mayumi; H Mikawa
Journal:  Immunol Lett       Date:  1990 Mar-Apr       Impact factor: 3.685

3.  Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE.

Authors:  Y Yanagihara; M Sarfati; D Marsh; T Nutman; G Delespesse
Journal:  Clin Exp Allergy       Date:  1990-07       Impact factor: 5.018

4.  Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study.

Authors:  P G Burney; J R Britton; S Chinn; A E Tattersfield; A O Papacosta; M C Kelson; F Anderson; D R Corfield
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

5.  Associations between asthma history, atopy, and non-specific bronchial responsiveness in young adults.

Authors:  W O Cookson; A W Musk; G Ryan
Journal:  Clin Allergy       Date:  1986-09

6.  Peripheral blood T lymphocytes in seasonal bronchial asthma.

Authors:  J Monteseirín; P Guardia; J Delgado; E Llamas; J Palma; A Conde; J Conde
Journal:  Allergy       Date:  1995-02       Impact factor: 13.146

Review 7.  Consequences of IgE/CD23-mediated antigen presentation in allergy.

Authors:  G C Mudde; R Bheekha; C A Bruijnzeel-Koomen
Journal:  Immunol Today       Date:  1995-08

8.  CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status.

Authors:  C J Corrigan; A B Kay
Journal:  Am Rev Respir Dis       Date:  1990-04

9.  CD23: a multi-functional receptor/lymphokine?

Authors:  J Gordon; L Flores-Romo; J A Cairns; M J Millsum; P J Lane; G D Johnson; I C MacLennan
Journal:  Immunol Today       Date:  1989-05

10.  Serum levels of soluble IL-2R, CD4 and CD8 in bronChial asthma.

Authors:  G D Lorenzo; P Mansueto; M Melluso; G Morici; F Norrito; D Cigna; G Candore; C Caruso
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

View more
  3 in total

1.  Soluble CD23 controls IgE synthesis and homeostasis in human B cells.

Authors:  Alison M Cooper; Philip S Hobson; Mark R Jutton; Michael W Kao; Binia Drung; Boris Schmidt; David J Fear; Andrew J Beavil; James M McDonnell; Brian J Sutton; Hannah J Gould
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

Review 2.  Omalizumab and IgE in the Control of Severe Allergic Asthma.

Authors:  Yasuhiro Gon; Shuichiro Maruoka; Kenji Mizumura
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

3.  Soluble CD23 levels are inversely associated with atopy and parasite-specific IgE levels but not with polyclonal IgE levels in people exposed to helminth infection.

Authors:  Nadine Rujeni; Norman Nausch; Nicholas Midzi; Reginald Gwisai; Takafira Mduluza; David W Taylor; Francisca Mutapi
Journal:  Int Arch Allergy Immunol       Date:  2013-05-14       Impact factor: 2.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.